Large Firms Lead AI Adoption Census Data Highlights Enterprise Use New York Fed Study Highlights Disproportionate Impact of Rising Gas Prices on LowerIncome Households South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Unrest Plus500 Reports 11 Revenue Growth Confirms FullYear Guidance The AI Economy May Reshape the American Dream Giving BlueCollar Workers an Edge Amazon Reports BestEver Thanksgiving Holiday Week with Record Sales and Items Sold ADGM Q1 2026 Earnings EPS Misses Estimates Revenue Not Reported Brookfield Renewable Partners Q1 2026 Earnings Widely Missed EPS Estimates as Operating Challenges Persist BMRA Q1 2026 Earnings Biomerica Reports Net Loss of 044 Per Share Amid Ongoing Development Efforts Five9 Q1 2026 Earnings EPS Surpasses Estimates by 913 as Stock Gains 421 COPEL Q2 2025 Earnings Strong EPS Beat of 5848 Despite Marginal Stock Decline TFS Financial Corporation Q1 2026 Earnings EPS Slightly Misses Estimates Amid Stable Operations Qwest Corporation 675 Notes CTDD Advance 114 as Bond Market Stabilizes DirectBooking Technology ZDAI Bounces from Support Levels Eyes Resistance at 214 HeartSciences Inc HSCS Slips 25 as Shares Test Key Support Zone Cirrus Logic Shares Decline Amid Broad Tech SellOff Key Support Levels Tested RenovoRx Inc RNXT Hovers Near Support as Thin Trading Persists Dropbox CoFounder Drew Houston to Transition from CEO to Executive Chairman After 19Year Tenure ZBIO Q1 2026 Earnings Narrower Loss Surprises Analysts as Pipeline Progress Continues Oramed Pharmaceuticals ORMP Drops 89 Support Level Under Pressure PDLB Q4 2025 Earnings EPS Surges Past Estimates Revenue Details Withheld SNAP Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Edges Higher NWPX Q1 2026 Earnings Earnings Surge Past Estimates with 5571 Surprise CCIF Q1 2026 Earnings Net Investment Income Misses Estimates Despite Small Stock Gain Forte Biosciences Q1 2026 Earnings Prerevenue Biotech Misses EPS Estimates Stock Dips on Narrower Loss Miss Resideo Technologies REZI Q1 2026 Earnings EPS Beats Estimates by 533 Stock Edges Lower OVID Q1 2026 Earnings Narrower Loss and No Revenue Mark a Quiet Quarter for the Biotech